MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

MDT

100.71

-0.28%↓

A

135.73

+0.63%↑

VEEV

223.72

+0.88%↑

HQY

85.01

+1.03%↑

NEOG

10

+1.94%↑

Search

Smith & Nephew PLC ADR

Затворен

33.72 1.29

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

33.29

Максимум

33.9

Ключови измерители

By Trading Economics

Приходи

296M

Продажби

3B

P/E

Средно за сектора

29.196

89.037

Дивидентна доходност

2.33

Марж на печалбата

9.895

Служители

17,000

EBITDA

723M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+3.45% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.33%

2.18%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

14B

Предишно отваряне

32.43

Предишно затваряне

33.72

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Smith & Nephew PLC ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.01.2026 г., 23:49 ч. UTC

Горещи акции

Stocks to Watch: Agilysys, Nucor, Humana, UnitedHealth

26.01.2026 г., 23:09 ч. UTC

Значими двигатели на пазара

Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate

26.01.2026 г., 23:52 ч. UTC

Пазарно говорене

Gold's Path of Least Resistance Still Looks Higher, Technical Analysis Shows -- Market Talk

26.01.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Decline as Yen's Rebound Raises Caution Over Earnings -- Market Talk

26.01.2026 г., 23:37 ч. UTC

Пазарно говорене

Gold Rises Amid Concerns Over Tariffs -- Market Talk

26.01.2026 г., 22:41 ч. UTC

Пазарно говорене

Australian 4Q CPI To Provide Smoking Gun For Hike -- Market Talk

26.01.2026 г., 22:26 ч. UTC

Печалби

Karoon Expects Capex of US$110 Million-US$135 Million in 2026

26.01.2026 г., 22:26 ч. UTC

Печалби

Karoon Expects Operating Costs to Fall Once Transition of Bauna FPSO Operatorship Completes

26.01.2026 г., 22:25 ч. UTC

Печалби

Karoon Energy Expects Unit Production Cost of US$12-US$15/BOE in 2026

26.01.2026 г., 22:25 ч. UTC

Печалби

Karoon Energy Expects Output to Rise in 2H Following Bauna Investment Program

26.01.2026 г., 22:25 ч. UTC

Печалби

Karoon Energy Expects Output of 8.1 Million-9.2 Million BOE in 2026

26.01.2026 г., 22:24 ч. UTC

Печалби

Karoon Energy 4Q Sales Revenue US$156.1 Million

26.01.2026 г., 22:23 ч. UTC

Печалби

Karoon Energy 4Q Sales Volumes 2.65 Million BOE, Up 5% on Quarter

26.01.2026 г., 22:23 ч. UTC

Печалби

Karoon Energy: Bauna FPSO Efficiency Increased to 98.8%

26.01.2026 г., 22:23 ч. UTC

Печалби

Karoon Energy FY Oil, Natural Gas Production 10.3 Million BOE

26.01.2026 г., 22:22 ч. UTC

Печалби

Karoon Energy 4Q Oil, Natural Gas Production 2.37 Million BOE

26.01.2026 г., 22:05 ч. UTC

Придобивния, сливания и поглъщания

Fortescue: Alta Copper Shareholders Approve Takeover

26.01.2026 г., 22:02 ч. UTC

Придобивния, сливания и поглъщания

Senate Antitrust Panel Chair Raises Concerns Over Netflix-Warner Deal -- WSJ

26.01.2026 г., 21:50 ч. UTC

Пазарно говорене
Печалби

Financial Services Roundup: Market Talk

26.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

26.01.2026 г., 21:34 ч. UTC

Печалби

Nucor: Steel Products Segment Expected Improved Earnings in 1Q Due to Increased Volumes on Stable Pricing >NUE

26.01.2026 г., 21:34 ч. UTC

Печалби

Nucor: Steel Mills Segment Expected Increase Is Due to Higher Volumes and Higher Realized Prices Across All Major Pdt Categories >NUE

26.01.2026 г., 21:34 ч. UTC

Печалби

Nucor: Raw Materials Segment Is Expected to Have Increased Earnings in 1Q >NUE

26.01.2026 г., 21:34 ч. UTC

Печалби

Nucor: 1Q Earnings Expected to Increase Across All Three Operating Segments, With the Largest Increase in Steel Mills Segment >NUE

26.01.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Eaton Stock Rises on Spin-Off Plan. Why It's Going All-In on Planes and AI Data Centers. -- Barrons.com

26.01.2026 г., 21:30 ч. UTC

Печалби

Nucor 4Q Sales $7.69B >NUE

26.01.2026 г., 21:30 ч. UTC

Печалби

Nucor 4Q Net $378M >NUE

26.01.2026 г., 21:30 ч. UTC

Печалби

Nucor 4Q Steel Mills Total Shipments 5.91M Tons >NUE

26.01.2026 г., 21:30 ч. UTC

Печалби

Nucor 4Q Total Tons Shipped to Outside Customers Down 9% >NUE

26.01.2026 г., 21:30 ч. UTC

Печалби

Nucor 4Q EPS $1.64 >NUE

Сравнение с други в отрасъла

Ценова промяна

Smith & Nephew PLC ADR Прогноза

Ценова цел

By TipRanks

3.45% нагоре

12-месечна прогноза

Среден 34.46 USD  3.45%

Висок 34.91 USD

Нисък 34 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Smith & Nephew PLC ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

2 ratings

0

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

26.64 / 28.37Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat